LEADER 05169nam 2200673 450 001 9910144847603321 005 20170810195508.0 010 $a1-282-11843-9 010 $a9786612118432 010 $a3-527-61129-0 010 $a3-527-61669-1 035 $a(CKB)1000000000687688 035 $a(EBL)481666 035 $a(OCoLC)609855389 035 $a(SSID)ssj0000354202 035 $a(PQKBManifestationID)11245281 035 $a(PQKBTitleCode)TC0000354202 035 $a(PQKBWorkID)10302439 035 $a(PQKB)10104754 035 $a(MiAaPQ)EBC481666 035 $a(PPN)158038258 035 $a(EXLCZ)991000000000687688 100 $a20160818h20082008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aFinancing health care $enew ideas for a changing society /$fedited by Mingshan Lu and Egon Jonsson 210 1$aWeinheim, [Germany] :$cWiley-VCH Verlag GmbH & Co. KGaA,$d2008. 210 4$dİ2008 215 $a1 online resource (293 p.) 225 1 $aHealth Care and Disease Management ;$vv.2 300 $aDescription based upon print version of record. 311 $a3-527-32027-X 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aFinancing Health Care; Contents; Preface; List of Contributors; 1 Introduction; 1.1 Health Systems Reform; 1.2 Aging Populations and Advanced Medical Technology; 1.3 Decentralization; 1.4 The Content of this Book; References; 2 Social Health Insurance: Government Funding of Health Care; 2.1 Introduction; 2.2 Health Services, Health Insurance, and Market Failure; 2.3 Different Models for Government Funding of Health Care; 2.4 Conclusion: The Future of Social Health Insurance in Canada; References; 3 Private Financing Outside the Publicly Funded System 327 $a3.1 Introduction and the Evolution of Private Financing in Canada3.2 Reviewing Economic Theory and Evidence on Parallel Public and Private Financing Structures; 3.3 OECD Evidence on Private Financing; 3.4 Overall Conclusions and Directions for Further Study; References; 4 Prescription Drug Financing; 4.1 Introduction; 4.2 Drug Expenditures and Financing in Canada and Abroad; 4.3 Unique Aspects of Pharmaceuticals and the Pharmaceutical Sector; 4.4 Considerations for Pharmaceutical Financing Reform; 4.5 Conclusion; References; 5 The Economics of Consumer-Directed Health Care; 5.1 Introduction 327 $a5.2 Consumer-Preventive Care Decisions5.3 Selection and Cross-Subsidization; 5.4 Health Care Demand and Non-Linear Prices; 5.5 Empirical Studies of Consumer-Directed Health Care; 5.6 Conclusion; References; 6 Medical Savings Accounts: Promises and Pitfalls; 6.1 Introduction; 6.2 MSA Financing Internationally; 6.3 MSA Financing and System Performance; 6.4 Conclusions; References; 7 Physician Payment Mechanisms; 7.1 Introduction; 7.2 A Basic Model of Health-Care Provision and Consumption; 7.3 Traditional Fee-For-Service (FFS); 7.4 Capitation and Fully Prospective Payments 327 $a7.5 Mixed-Payment Systems7.6 Concluding Remarks; References and Footnotes; 8 Risk Adjustment in Health Care Markets: Concepts and Applications; 8.1 Overview; 8.2 Introduction; 8.3 Theory; 8.4 Estimation Issues; 8.5 Country Experience with Risk Adjustment; 8.6 Conclusions; References; 9 Inducing Quality from Health Care Providers in the Presence of Adverse Selection; 9.1 Introduction; 9.2 The Basic Adverse Selection Problem; 9.3 Dealing with Adverse Selection; 9.4 The Regulator Can Observe Quality, But Consumers Cannot: Choosing What to Report 327 $a9.5 Consumers Can Observe Quality and the Regulator Can Observe "Signals" About Consumers' Types: Risk Adjustment9.6 Concluding Remarks; References; 10 Equity in Health and Health Care in Canada in International Perspective; 10.1 Overview; 10.2 Introduction: Canada's Health Care System and Equity; 10.3 Income-Related Inequity in Access to, and Delivery of, Care; 10.4 Inequalities in Health and Health Outcomes; 10.5 Conclusion and Discussion; References; Index 330 $aDiscussing international issues of health care financing, this is the first volume in a completely new public health book series, edited by the Institute of Health Economics (IHE) in Edmonton, Canada.Starting with various funding methods, the reference also features sections on different health care payment and purchasing mechanisms, as well as equity issues.Of interest to medical and allied health professionals, and those working in health care industries, insurance, and economics. 410 0$aHealth Care and Disease Management 606 $aMedical care$zCanada$xFinance 606 $aMedical care, Cost of$zCanada 606 $aHealth insurance$zCanada 615 0$aMedical care$xFinance. 615 0$aMedical care, Cost of 615 0$aHealth insurance 676 $a362.10681 702 $aLu$b Mingshan 702 $aJonsson$b Egon 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910144847603321 996 $aFinancing Health Care$9459909 997 $aUNINA